Dolby Laboratories, Inc.
DLBNYSETechnology● Active
$54.01
+$0.23(+0.43%)
Market Cap$5.2B
P/E Ratio—
52W High$77
52W Low$52.45
Dolby Laboratories, Inc.（DLB）· 资产负债表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · DLB · 截至 2026-06-10
财务报表
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-09 | 2024-09 | 2023-09 | 2022-09 | 2021-09 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $0.70B | $0.58B | $0.96B | $0.82B | $1.27B |
| Net Receivables | $0.51B | $0.51B | $0.44B | $0.42B | $0.41B |
| Inventory | $0.03B | $0.03B | $0.04B | $0.02B | $0.01B |
| Total Current Assets | $1.39B | $1.19B | $1.49B | $1.31B | $1.76B |
| PP&E Net | $0.50B | $0.52B | $0.52B | $0.56B | $0.60B |
| Goodwill | $0.53B | $0.53B | $0.41B | $0.37B | $0.34B |
| Intangible Assets | $0.40B | $0.43B | $0.17B | $0.11B | $0.12B |
| Total Assets | $3.23B | $3.13B | $2.99B | $2.70B | $3.12B |
| Liabilities | |||||
| Short-Term Debt | $0.00B | $0.01B | $0.01B | $0.01B | $0.02B |
| Accounts Payable | $0.02B | $0.02B | $0.02B | $0.01B | $0.02B |
| Total Current Liabilities | $0.44B | $0.42B | $0.42B | $0.28B | $0.32B |
| Long-Term Debt | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Liabilities | $0.60B | $0.64B | $0.62B | $0.45B | $0.52B |
| Stockholders Equity | |||||
| Retained Earnings | $2.63B | $2.50B | $2.39B | $2.30B | $2.61B |
| Total Stockholders Equity | $2.62B | $2.48B | $2.36B | $2.25B | $2.60B |
| Total Liab & Equity(computed) | $3.22B | $3.12B | $2.98B | $2.70B | $3.12B |
| Debt Summary | |||||
| Total Debt | $0.04B | $0.05B | $0.05B | $0.05B | $0.07B |
| Net Debt | ($0.66B) | ($0.53B) | ($0.77B) | ($0.58B) | ($1.16B) |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解Dolby Laboratories, Inc.
关于Dolby Laboratories, Inc.（DLB）资产负债表
Dolby Laboratories, Inc.总资产$3.23B，现金及短期投资$0.70B，总负债$0.60B，总债务$0.04B，股东权益$2.62B。
常见问题
DLB · 4 问Dolby Laboratories, Inc.总债务$0.04B，净债务($0.66B)。
DLB total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10